← All trials
NCT05547061
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 12, 2021
- Primary completion
- Aug 31, 2023
- Completion date
- Dec 31, 2023
- First posted
- Sep 21, 2022
- Last posted
- Sep 23, 2022
- Enrollment
- 73
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Cellbion Co., Ltd.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.